Drug Trial Radar · NCT06150924
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
Last checked: Nov 19, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Dec 14, 2023
Primary completion
Feb 27, 2025
Study completion Apr 23, 2025
Sponsor
- Lead sponsor
- Mineralys Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 29, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind (DB), placebo controlled, crossover study with a two-period, two-sequence (2x2) design evaluating the efficacy and safety of 25 mg QD lorundrostat (an aldosterone synthase inhibitor \[ASI\]) in addition to a SGLT2i for the treatment of hypertension in subjects with CKD and albuminuria while receiving stable treatment with an Angiotensin-converting enzyme inhibitor (ACEi) or an Angiotensin receptor blocker (ARB). Subjects will be at least 18 years old with hypertension, and mild to severe CKD with albuminuria at the Screening Visit.
Conditions
- Chronic Kidney Disease
Interventions
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QDDrug
Period 1 - Lorundrostat 25mg QD + SGLT2i QD 4 weeks; Washout - Placebo QD + SGLT2i QD 4 weeks; Period 2 - Placebo QD + SGLT2i QD 4 weeks
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QDDrug
Period 1 - Placebo QD + SGLT2i QD 4 weeks; Washout - Placebo QD + SGLT2i QD 4 weeks; Period 2 - Lorundrostat 25mg + SGLT2i QD 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Placebo-adjusted Change From Baseline in Automated Office Blood Pressure (AOBP) Systolic Blood Pressure (SBP) at Week 4Time frame: Baseline to Week 4
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Arizona Kidney Disease & Hypertension Centers (AKDHC) - Thunderbird Office
Glendale, Arizona
Arizona Kidney Disease & Hypertension Centers (AKDHC) - Thomas Office
Phoenix, Arizona
Balboa Nephrology Medical Group, Inc. (BNMG) - California Institute of Renal Research (CIRR) - Chula Vista
Chula Vista, California
Balboa Nephrology Medical Group, Inc. (BNMG) - El Centro
El Centro, California
Amicis Research Center - Granada Hills
Granada Hills, California
Balboa Nephrology Medical Group, Inc. (Bnmg) - La Mesa
La Mesa, California
Academic Medical Research Institute (AMRI) - Los Angeles
Los Angeles, California
Amicis Research Center
Northridge, California
Amicis Research Center - Vacaville
Vacaville, California
Colorado Kidney Care (Denver Nephrology) - Denver Office
Denver, Colorado
Qway Research
Coconut Grove, Florida
Indago Research and Health Center
Hialeah, Florida
Elixia Pines, LLC
Hollywood, Florida
Elixia Central Florida, LLC
Orlando, Florida
Infigo Clinical Research, Llc
Sanford, Florida
Genesis Clinical Research - Tampa
Tampa, Florida
Palm Beach Diabetes and Endocrine Specialists, PA (PBDES) - West Palm Beach Office
West Palm Beach, Florida
American Clinical Trials Llc
Acworth, Georgia
Nephrology of the Golden Isles - Brunswick
Brunswick, Georgia
ClinCept, LLC
Columbus, Georgia
Georgia Nephrology, Llc
Lawrenceville, Georgia
Nephrology Associates of Kentuckiana, PSC (NAK)
Louisville, Kentucky
Lcms Health University Medical Center New Orleans
New Orleans, Louisiana
Northwest Louisiana Nephrology, Llc - Shreveport
Shreveport, Louisiana
Tufts University School of Medicine (Tusm) - Tufts Medical Center (Tmc) (Tufts-New England Medical Center)
Boston, Massachusetts
Elixia MKC, LLC
Pontiac, Michigan
Kansas City Kidney Consultants (Arms, Dodge, Robinson, Wilber & Crouch, Inc.) - Kansas City
Kansas City, Missouri
Seacoast Kidney & Hypertension Specialists - Portsmouth Office
Portsmouth, New Hampshire
Suny Downstate Medical Center - Parkside Dialysis Center
Brooklyn, New York
Nephrology Associates, PC
Fresh Meadows, New York
Nephrology Associates
Fresh Meadows, New York
Triad Internal Medicine
Asheboro, North Carolina
Nephrology Associates, Pllc - Winston-Salem
Winston-Salem, North Carolina
Nephrology Consultants - Oklahoma City
Oklahoma City, Oklahoma
Columbia Nephrology
Columbia, South Carolina
Southeast Renal Research Institute
Chattanooga, Tennessee
Dallas Nephrology Associates (Dna) - Renal Disease Research Institute (Rdri)
Dallas, Texas
Liberty Research Center
Dallas, Texas
R&H Clinical Research
Katy, Texas
E T Nephrology Associates - Lufkin
Lufkin, Texas
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.